SAM.GOVDue: April 23, 2025 at 08:00 PM UTCIn-ActiveSpecial NoticeSource Url
Summary
The opportunity titled '6505--Bulk Order Impavido (miltefosine)' is a special notice issued by the Department of Veterans Affairs, specifically the Puget Sound VA Medical Center, indicating a sole source procurement for the drug Impavido, which is essential for treating Veterans with Disseminated Cutaneous Acanthamboeba. The contract is set to be awarded to Profounda, Inc., the sole manufacturer and license holder of this medication in the United States. The period of performance for this contract is from May 1, 2025, to October 30, 2025, with a total estimated value of $299,700. This opportunity is particularly relevant for businesses that specialize in pharmaceutical manufacturing and distribution, especially those with capabilities to provide unique medical treatments that are not available from other sources.